Shots: Alcon is removing CyPass globally revealing its unmet needs with safety of patients with the guidance for surgeons to stop its further use and return the fresh devices The above decision is on the basis of five-year data from COMPASS-XT long-term safety study The study showed reduction in intraocular pressure at two yrs, resulting […]Read More
Tags : CyPass Micro-Stent
Latest Posts
Categories
Related Topics
AbbVie
Acquire
Adults
Agreement
Amgen
approval
AstraZeneca
Bayer
Biosimilar
BMS
Collaborate
Collaborates
Collaboration
Commercialize
COVID-19
Develop
Development
Eli Lilly
EU
Exclusive
FDA
Gilead
GSK
Janssen
Launches
License
License Agreement
Merck
Novartis
P-III
patients
Pfizer
receives
Report
reports
results
Roche
Sanofi
Signs
study
Takeda
the US FDA
Treat
Treatment
US